World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 6 November 2023
Main ID:  NCT02436226
Date of registration: 02/05/2015
Prospective Registration: Yes
Primary sponsor: Mohamed Sayed Abdelhafez
Public title: Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
Scientific title: Use of Low Dose of Human Chorionic Gonadotropin During Ovulation Induction With Clomiphene Citrate in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome
Date of first enrolment: March 2016
Target sample size: 300
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02436226
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Egypt
Contacts
Name:     Mahmoud M Abdel-razik, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Khaled S Ismael, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Maged R Elshamy, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Ahmed Ragab, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Hamed Youssef, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Mohamed A Elnegery, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Mahmoud Thabet, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Name:     Mohamed S Abdelhafez, MD
Address: 
Telephone:
Email:
Affiliation:  Mansoura University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Infertile lean women with PCOS as defined by the Rotterdam criteria.

- CC resistance (defined as failure of ovulation after receiving 150 mg/day of CC for 5
consecutive days per cycle, for at least 3 consecutive cycles).

Exclusion Criteria:

- Age < 20 or > 35 years.

- Presence of any infertility factor other than anovulatory PCOS.

- Previous history of ovarian surgery or surgical removal of one ovary.

- Previous exposure to cytotoxic drugs or pelvic irradiation.

- Oral hypoglycemic or hormonal therapy either currently or in the preceding 3 months.

- Metabolic or hormonal abnormalities.



Age minimum: 20 Years
Age maximum: 35 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Polycystic Ovarian Syndrome
Infertility
Intervention(s)
Drug: Clomiphene citrate and Human chorionic gonadotropin (HCG)
Drug: Clomiphene citrate
Primary Outcome(s)
Ovulation rate [Time Frame: 3 months]
Secondary Outcome(s)
Clinical pregnancy rate [Time Frame: 6-8 weeks gestational age]
Number of ovarian follicles = 18 mm on day of triggering of oocyte maturation [Time Frame: 3 months]
Endometrial thickness on day of triggering of oocyte maturation [Time Frame: 3 months]
Incidence of early ovarian hyperstimulation syndrome (OHSS) [Time Frame: Within 9 days of final triggering of oocyte maturation]
Secondary ID(s)
MT1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history